MAPT and Alzheimer disease: AD is characterized by beta-amyloid (Aβ) accumulation, hyperphosphorylation of the tau protein (p-Tau), and cholinergic deficiency; however, potential treatment options focusing on these pathways have shown little efficacy [1,2].